Constance Baer

3.2k citations

79 papers · 1.1k indexed · h-index 17

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 51
- Acute Myeloid Leukemia Research 40
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 6
Genetics 39
- Myeloproliferative Neoplasms: Diagnosis and Treatment 21
- Chronic Lymphocytic Leukemia Research 17

Co-authors: Christoph Plass (6 shared papers)Rainer Claus (3 shared papers)Torsten Haferlach (66 shared papers)Wolfgang Kern (67 shared papers)Claudia Haferlach (64 shared papers)Manja Meggendorfer (58 shared papers)Stephan Hütter (42 shared papers)Stephan Stilgenbauer (2 shared papers)
Journals: Blood (44 papers)Leukemia (11 papers)Blood Advances (5 papers)Haematologica (4 papers)Cancer Research (2 papers)
Partner nations: Germany United States Australia

In The Last Decade

Constance Baer

64 papers receiving 1.1k citations

Peers

Countries citing papers authored by Constance Baer

Since Specialization

Citations

This map shows the geographic impact of Constance Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Baer more than expected).

Fields of papers citing papers by Constance Baer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Baer. The network helps show where Constance Baer may publish in the future.

Co-authors

The 25 scholars most cited alongside Constance Baer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Constance Baer Line = papers co-authored together Constance Baer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Genome-Wide Epigenetic Regulation of miRNAs in Cancer Cancer Research ·Constance Baer, Rainer Claus, Christoph Plass	2013	243
2	Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia Blood ·Maike Buchner, Constance Baer, Gabriele Prinz, Christine Dierks, Meike Burger, Thorsten Zenz, Stephan Stilgenbauer, Hassan Jumaa, Hendrik Veelken, Katja Zirlik	2010	144
3	Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia Cancer Research ·Constance Baer, Rainer Claus, Lukas P. Frenzel, Manuela Zucknick, Yoon Jung Park, Lei Gu, Dieter Weichenhan, Martina Fischer, Christian P. Pallasch, Esther Herpel, Michael Rehli, John C. Byrd, Clemens‐Martin Wendtner, Christoph Plass	2012	109
4	Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia International Journal of Cancer ·Constance Baer, Christopher C. Oakes, Amy S. Ruppert, Rainer Claus, Soo-Zin Kim-Wanner, Daniel Mertens, Thorsten Zenz, Stephan Stilgenbauer, John C. Byrd, Christoph Plass	2015	51
5	Oncogenic role of miR‐155 in anaplastic large cell lymphoma lacking the t(2;5) translocation The Journal of Pathology ·Olaf Merkel, Frank Hamacher, Robert Griessl, Lisa Grabner, Ana‐Iris Schiefer, Nicole Prutsch, Constance Baer, Gerda Egger, Michaela Schlederer, Peter W. Krenn, Tanja Nicole Hartmann, Ingrid Simonitsch‐Klupp, Christoph Plass, Philipp B. Staber, Richard Moriggl, Suzanne D. Turner, Richard Greil, Lukas Kenner	2015	44
6	Temporal pulse compression in a xenon-filled Kagome-type hollow-core photonic crystal fiber at high average power Optics Express ·Oliver H. Heckl, Clara J. Saraceno, Constance Baer, Thomas Südmeyer, Yingying Wang, Yi Cheng, F. Benabid, U. Keller	2011	43
7	Complex landscape of alternative splicing in myeloid neoplasms Leukemia ·Courtney E. Hershberger, Devlin C. Moyer, Vera Ademà, Cassandra M Kerr, Wencke Walter, Stephan Hütter, Manja Meggendorfer, Constance Baer, Wolfgang Kern, Niroshan Nadarajah, Sven Twardziok, Mikkael A. Sekeres, Claudia Haferlach, Torsten Haferlach, Jaroslaw P. Maciejewski, Richard A. Padgett	2020	37
8	Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies Blood Advances ·Anna Stengel, Constance Baer, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	2021	36
9	Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia Haematologica ·Constance Baer, Wolfgang Kern, S. Koch, Niroshan Nadarajah, Sonja Schindela, M. Meggendorfer, Claudia Haferlach, Torsten Haferlach	2016	34
10	Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma Epigenetics ·Benjamin Goeppert, Christina Ernst, Constance Baer, Stéphanie Roessler, Marcus Renner, Arianeb Mehrabi, Mohammadreza Hafezi, Anita Pathil, Arne Warth, Albrecht Stenzinger, Wilko Weichert, Marion Bähr, Rainer Will, Peter Schirmacher, Christoph Plass, Dieter Weichenhan	2016	34
11	AML classification in the year 2023: How to avoid a Babylonian confusion of languages Leukemia ·Sandra Huber, Constance Baer, Stephan Hütter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann	2023	32
12	Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse American Journal of Hematology ·Licia Iaccarino, Tiziana Ottone, Valentina Alfonso, Laura Cicconi, Mariadomenica Divona, Serena Lavorgna, Serena Travaglini, Aleandra Ferrantini, Giulia Falconi, Constance Baer, Monica Usai, Fabio Forghieri, Adriano Venditti, Maria Ilaria Del Principe, William Arcese, Maria Teresa Voso, Torsten Haferlach, Francesco Lo‐Coco	2019	30
13	Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification Blood Advances ·Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hütter, Constance Baer, Martijn W. Heymans, Peter J.M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach	2021	23
14	Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration Leukemia ·Luca Vincenzo Cappelli, Manja Meggendorfer, Constance Baer, Niroshan Nadarajah, Stephan Hütter, Sabine Jeromin, Frank Dicker, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Alexander Höllein	2021	23
15	The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? Cancer Genetics ·Alexander Höllein, Sven Twardziok, Wencke Walter, Stephan Hütter, Constance Baer, Jesús María Hernández-Sánchez, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach	2020	22
16	Risk prediction in MDS: independent validation of the IPSS-M—ready for routine? Leukemia ·Constance Baer, Sandra Huber, Stephan Hütter, Manja Meggendorfer, Niroshan Nadarajah, Wencke Walter, Uwe Platzbecker, Katharina S. Götze, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann, Claudia Haferlach	2023	19
17	SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis Leukemia ·Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hütter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach	2022	18
18	Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS Blood Advances ·Anna Stengel, Torsten Haferlach, Constance Baer, Stephan Hütter, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach	2023	16
19	Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS Blood Advances ·Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hütter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	2023	15
20	Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm—a comparison of 756 cases Leukemia ·Constance Baer, Christian Pohlkamp, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach	2018	14

About Constance Baer

Constance Baer is a scholar working on Hematology, Genetics, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 79 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (40 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (17 papers), Cancer Genomics and Diagnostics (14 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Hematology (386 citations), Genetics (336 citations), Cancer Research (424 citations), Pathology and Forensic Medicine (189 citations) and Molecular Biology (619 citations). Constance Baer has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Christoph Plass, Rainer Claus, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach, Manja Meggendorfer, Stephan Hütter, Stephan Stilgenbauer, Thorsten Zenz and Wencke Walter. Their work appears in journals such as Blood, Leukemia, Blood Advances, Haematologica and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact